About Creative Drug Industries
Creative Drug Industries is a Healthcare company based in Mumbai (India) founded in 2003 by Satish Sadanand Karekar, Vishwas Sadanand Karekar, and Deomani Tripathi. It provides allergy testing tools and immunotherapy for medical professionals and research. It operates on a B2B and Direct Sales model. Its Indian entity Creative Diagnostic Medicare Private Limited reported revenue of ₹6.73 Cr. Creative Drug Industries offers products and services including Skin Prick Test Allergens, Patch Test Allergens, Allergy Immunotherapy, and Concentrated Allergens for Research. Its focus areas include Diagnostics Tech, Allergy, Immunotherapy and Research Tech. Its competitors include Allergy Amulet, YorkTest, ATANIS Biotech, DST and Microtest Diagnostics and 3 more; 3 of its 8 listed competitors have raised funding.
Company details
Creative Diagnostic Medicare specializes in developing and supplying allergy diagnostics products, including skin prick test allergens and patch test allergens, along with immunotherapy solutions. The company operates from Navi Mumbai, India, focusing on quality and advanced technology for physicians and researchers. They also offer contract manufacturing and concentrated allergens for various applications, serving healthcare sectors through direct and business-to-business channels.
- Headquarters Mumbai, India
- Founders Satish Sadanand Karekar, Vishwas Sadanand Karekar, Deomani Tripathi
- SectorsHealthcare
- Email••••••••
- Website creativeallergy.com
- Social X Facebook
- Legal Name Creative Diagnostic Medicare Private Limited
- Date of Incorporation 11 Jun, 2003
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹6.73 Cr
FY 2025 · +5% YoY
- Net Profit₹1.34 Cr
FY 2025 · 20% margin
- EBITDA₹1.82 Cr
FY 2025 · 27% margin
Associated legal entities of Creative Drug Industries
Creative Drug Industries operates through Creative Diagnostic Medicare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Creative Diagnostic Medicare Private Limited CIN U24230MH2003PTC140840 | Active | 11 Jun 2003 | Navi Mumbai, Maharashtra | ₹6.7 Cr | – | 3 | View details |
Products & Services of Creative Drug Industries
Creative Drug Industries offers a comprehensive portfolio of products and services, including Skin Prick Test Allergens, Patch Test Allergens, Allergy Immunotherapy, and Concentrated Allergens for Research.
Products for allergy skin testing in clinical settings.
Allergens used for patch testing to identify allergies.
Therapies to desensitize patients against allergens.
Specialized allergens for scientific and medical research.
Board of directors of Creative Diagnostic Medicare Private Limited (Creative Drug Industries)
Creative Diagnostic Medicare Private Limited is the primary company behind Creative Drug Industries. The board of Creative Diagnostic Medicare Private Limited currently have 3 directors; the longest-serving is Deoman Tripathi, appointed in 2003. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Deoman Tripathi DIN 03334485 | Director | 11 Jun 2003 | 23 yrs 4 mo | Creative Diagnostic Medicare Private Limited |
| Vishwas Sadanand Karekar DIN 00416586 | Director | 11 Jun 2003 | 23 yrs 4 mo | Creative Diagnostic Medicare Private Limited |
| Sushant Satish Karekar DIN 06696982 | Director | 09 Sep 2022 | 4 yrs 1 mo | Creative Diagnostic Medicare Private Limited |
People of Creative Drug Industries
3 people are tracked at Creative Drug Industries (3 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
Deomani Tripathi | Co-Founder | Leadership |
Complete people profiles for Creative Drug Industries
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Creative Drug Industries
Figures of Creative Diagnostic Medicare Private Limited, the primary company behind Creative Drug Industries, for FY 2025. Revenue was ₹6.73 Cr (+5% year on year). Net profit was ₹1.34 Cr (20% margin). EBITDA was ₹1.82 Cr (27% margin). Revenue has grown at a compounded annual rate of +12% over three years and +12% over five years.
- ₹6.73 CrRevenue · FY 2025 · +5% YoY
- ₹1.34 CrNet profit · 20% margin
- ₹1.82 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- +12%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Creative Diagnostic Medicare Private Limited are on its company page.
Detailed financial statements for Creative Drug Industries
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Creative Drug Industries
Creative Drug Industries has 8 listed competitors in our database, 3 of them funded. They include Allergy Amulet, YorkTest, ATANIS Biotech, DST and Microtest Diagnostics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| allergyamulet.com | 2016 | Madison, United States | $12.57M | – | Portable food allergen sensors are offered via an online platform. | |
| yorktest.com | 1982 | York, United Kingdom | $12.03M | 38 | At-home food and allergy test kits are developed by YorkTest. | |
| atanis-biotech.com | 2021 | Sursee, Switzerland | – | – | Developer of a cell-based assay for the diagnosis of allergies | |
| dst-diagnostic.com | 2005 | Schwerin, Germany | – | 42 | Innovative in-vitro diagnostic solutions are developed by DST. | |
| microtestdx.com | 2002 | London, United Kingdom | $2.5M | 6 | Functions as an automated allergy testing service. | |
| macroarraydx.com.ua | 2016 | Kiev, Ukraine | – | – | Allergen analyzers are provided for in-vitro IgE level determination. | |
| allergenis.com | 2017 | Hatfield, United States | – | – | Develops accurate allergy testing solutions for healthcare providers and patients. | |
| immunovent.com | 2012 | New York, United States | – | – | Diagnostic tests for allergies are developed using mucosal brush samples. |
Detailed competitors of Creative Drug Industries
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
10 companies that operate in the same segment as Creative Drug Industries (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Creative Drug Industries
Creative Drug Industries was founded in 2003.
Creative Drug Industries is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Creative Drug Industries, Creative Diagnostic Medicare Private Limited, reported revenue of ₹6.73 Cr for FY 2025, up 5% year on year.
Creative Diagnostic Medicare specializes in developing and supplying allergy diagnostics products, including skin prick test allergens and patch test allergens, along with immunotherapy solutions. The company operates from Navi Mumbai, India, focusing on quality and advanced technology for physicians and researchers. They also offer contract manufacturing and concentrated allergens for various applications, serving healthcare sectors through direct and business-to-business channels.
Creative Drug Industries's top competitors include Allergy Amulet, ATANIS Biotech and YorkTest.
Creative Drug Industries offers Skin Prick Test Allergens, Patch Test Allergens, Allergy Immunotherapy, and Concentrated Allergens for Research.
Creative Drug Industries operates through Creative Diagnostic Medicare Private Limited.
The legal entities of Creative Drug Industries currently have 3 directors, including Sushant Satish Karekar, Deoman Tripathi, Vishwas Sadanand Karekar.